SpecialtyVETPATH/Proscia
SpecialtyVETPATH, a private, pathologist-owned, and pathologist-directed veterinary pathology laboratory, has selected Proscia, a leading provider of digital and computational pathology solutions, to modernise its practice. The laboratory is digitising its operations on Concentriq, an enterprise software platform that spans diagnostic and research pathology.
The company says that as digital pathology continues to demonstrate confidence and efficiency gains, laboratories of all sizes are increasingly shifting from microscope to whole slide images. According to the SpecialtyVETPATH, this is especially true among laboratories like itself that perform both diagnostics and research, as they can realise the impact of the technology on both operations. However, most software platforms only offer solutions for one set of workflows, leaving these laboratories to face the added complexity, cost, and time to value that result from working with multiple vendors.
“Proscia’s Concentriq is purpose-built for both diagnostic and research pathology at an enterprise scale,” said Dr. Jennifer Ward, CEO and Laboratory Director of SpecialtyVETPATH. “It is really important to us to not compromise on quality and transition to solutions that expand our capabilities and give us opportunities to grow. Choosing Proscia gives us confidence that we will realise the full potential of our transformation.”
The company says that Proscia’s software will enable pathologists to drive confidence and efficiency gains in their day-to-day diagnostic and research operations. As well as the cloud-based software empowering the laboratory to work more collaboratively by broadening the pool of expertise available for veterinary pathology consultations and improving access to its pathologists for research groups. In deploying the open Concentriq platform, SpecialtyVETPATH will integrate its homegrown ZRex laboratory information system and pave the way for incorporating image analysis and artificial intelligence applications.
“We are humbled that SpecialtyVETPATH has put its trust in Proscia to see through its transition to digital pathology,” said David West, Proscia’s CEO. “Guided by their strong vision, Dr. Ward and her team are now well positioned to realise the promise of the technology today and capitalize on new opportunities as they emerge.”
